Please wait while the formulary information is being retrieved.
ASTEPRO ALLERGY (azelastine HCl)
- non-seasonal allergic stuffy and runny nose
- seasonal runny nose
- vasomotor rhinitis
- Children's Astepro Allergy Nasal Spray
- Azelastine Nasal Spray
- Astepro Allergy Nasal Spray
- By Indication
205.5 mcg (0.15 %) nasal spray
- Spray 1 spray (205.5 mcg) in each nostril by intranasal route 2 timesper day
azelastine 205.5 mcg (0.15 %) nasal spray
- Spray 1 spray (205.5 mcg) in each nostril by intranasal route 2 timesper day
205.5 mcg (0.15 %) nasal spray
- Spray 1 spray (205.5 mcg) in each nostril by intranasal route 2 timesper day
Perennial allergic rhinitis
- Spray 2 sprays (411 mcg) in each nostril by intranasal route 2 times per day
Seasonal allergic rhinitis
- Spray 1 spray (205.5 mcg) in each nostril by intranasal route 2 timesper day
- Spray 2 sprays (411 mcg) in each nostril by intranasal route once daily
- Spray 2 sprays (411 mcg) in each nostril by intranasal route 2 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Drowsy
ASTEPRO ALLERGY (azelastine HCl)
- non-seasonal allergic stuffy and runny nose
- seasonal runny nose
- vasomotor rhinitis
- None
- Drowsy
- Dysesthesia
- Dysgeusia
- Headache disorder
More Frequent
Severe
Less Severe
- Cough
- Conjunctivitis
- Dizziness
- Epistaxis
- Fatigue
- Myalgia
- Nasal passage irritation
- Nausea
- Pharyngitis
- Rhinitis
- Sneezing
- Weight gain
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Atrial fibrillation
- Blurred vision
- Bronchospastic pulmonary disease
- Hematuria
- Ocular pain
- Pruritus of skin
- Skin rash
- Stomatitis
- Tachycardia
- Urinary retention
- Visual changes
Less Severe
- Acute confusion
- Aphthous stomatitis
- Chest pain
- Constipation
- Contact dermatitis
- Depression
- Diarrhea
- Dry eye
- Dyspnea
- Eczema
- Eye tearing
- Facial edema
- Flushing
- Folliculitis
- Furunculosis
- Gastroenteritis
- Glossitis
- Hyperkinesis
- Hypertension
- Hypoesthesia
- Increased appetite
- Lacerations
- Lesion of nasal mucosa
- Loss of sense of smell
- Nervousness
- Palpitations
- Paresthesia
- Parosmia
- Sleep disorder
- Symptoms of anxiety
- Toothache
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Azelastine (0.15% or combination)
Safety and efficacy not established age < 6 years. 0.1% azelastine approved for age 6 months and older.
- 1 Day – 6 Years
- Safety and efficacy not established age < 6 years. 0.1% azelastine approved for age 6 months and older.
Azelastine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Azelastine
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Perennial allergic rhinitis | |
| J31.0 | Chronic rhinitis |
| Seasonal allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| Vasomotor rhinitis | |
| J30.0 | Vasomotor rhinitis |
| 0-9 | A-Z |
|---|---|
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J31.0 | Chronic rhinitis |
Formulary Reference Tool